At 8.5% CAGR, the North America Infant, Child, and Maternal Probiotic Supplements Market is projected to be worth US$ 386.82 million by 2028, says Business Market Insights           

According to Business Market Insights’ research, the North America infant, child, and maternal probiotic supplements market was valued at US$ 237.56 million in 2022 and is expected to reach US$ 386.82 million by 2028, registering an annual growth rate of 8.5% from 2022 to 2028. Rising demand for probiotic supplements in pediatric nutrition and growing awareness regarding benefits of probiotic supplements among pregnant women are the critical factors attributed to the market expansion.                  

Apart from having a wholesome diet, pregnant women are seeking various alternatives to support their fitness and the health of their unborn babies. Digestive problems, such as constipation, diarrhea, acidity, and inflammation, are common during pregnancy. Probiotic supplements can help in battling these issues, ensuring a healthy gut. A mother’s microbiome is believed to be crucial in maintaining her and her baby’s health. An infant is exposed to millions of microbes while passing through the birth canal. Therefore, mothers must have a diet full of good bacteria to transfer to the newborn. Recently, probiotic dietary supplements for pregnant women have witnessed a high demand. Probiotic supplementation during pregnancy has several benefits. A thoroughly researched probiotic strains help improve bowel movement and relieve constipation problems. Studies have proven that including probiotic supplements in the regular diet of a pregnant woman help reduce inflammation, acidity, and bloating. Consumption of probiotic supplements during pregnancy also reduces the risk of vaginal infections, decreasing the chances of colic, eczema, and other allergies in newborn babies. Additionally, probiotics lower the risk of pre-eclampsia in pregnant women, a health condition resulting in high blood pressure and high protein levels in urine. Probiotic supplements also ensure better immunity for pregnant women, which helps fight chronic diseases and ensure good health of the baby. Lactobacillus acidophilus, Bifidobacterium bifidum, and Saccharomyces boulardii are among the most effective and widely used probiotic strains in prenatal probiotic supplements. These strains help to maintain a healthy intestinal flora and reduce the risk of various allergies, diseases, and complications, including gestational diabetes and pre-eclampsia. The growing awareness about the benefits of probiotic supplements among pregnant women is substantially driving the infant, child, and maternal probiotic supplements market.

On the contrary, consumer perceptions on probiotic supplements for newborn hampers market North America infant, child, and maternal probiotic supplements market. 

Based on form market is segmented into capsules and soft gels, gummies, liquid, and others. The others segment held 41.79% market share in 2022, amassing US$ 99.27 million. It is projected to garner US$ 160.77 million by 2028 to expand at 8.4% CAGR during 2022–2028.    

Based on end user, the North America infant, child, and maternal probiotic supplements market is segmented into into infant and toddler, children, and maternal women. The children segment held 56.18% market share in 2022, amassing US$ 133.54 million. It is projected to garner US$ 214.70 million by 2028 to expand at 8.2% CAGR during 2022–2028.

Based on country, the North America infant, child, and maternal probiotic supplements market has been categorized into US, Canada and Mexico. Our regional analysis states that US captured 85.82% market share in 2022. It was assessed at US$ 203.88 million in 2022 and is likely to hit US$ 326.78 million by 2028, exhibiting a CAGR of 8.2% during the forecast period.            

Key players dominating the North America infant, child, and maternal probiotic supplements market are Bayer Corporation; MaryRuth Organics, LLC; Mommy’s Bliss Inc.; Pharmavite LLC; Nestlé S.A.; BioGaia AB; Evolve Biosystems; Lovebug Probiotics; Biomeology; and Nordic Naturals.

•  In 2022; Mommy's Bliss introduced nine new products in 2022, made in the United States and Canada. The new products from Mommy's Bliss center were focused on postnatal care for mothers, sleep support and eczema relief for babies.

• In 2022; Pharmavite LLC expanded into the Columbus Region, the US, by investing more than $200 million and creating 225 new jobs.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com